NICE guidance - cardiovascular risk estimation in type 1 and type 2 diabetes
Last reviewed 12/2020
Primary prevention for people with type 1 diabetes
- statin treatment should be considered for the primary prevention of CVD
in all adults with type 1 diabetes
- statin treatment should be offered for the primary prevention of CVD to
adults with type 1 diabetes who:
- are older than 40 years or
- have had diabetes for more than 10 years or
- have established nephropathy or
- have other CVD risk factors
- start treatment for adults with type 1 diabetes with atorvastatin 20 mg
Primary prevention for people with type 2 diabetes
- offer atorvastatin 20 mg for the primary prevention of CVD to people with type 2 diabetes who have a 10% or greater 10-year risk of developing CVD.
- estimate the level of risk using the QRISK2 assessment tool
Reference: